"Press Release: Palatin Technologies Announces Litigation Settlement With Competitive Technologies"
SeekPeptides members access female-specific nutrition protocols and protein target calculators designed specifically for the appetite suppression phases of GLP-1 titration
as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters)
This is one of the most interesting and underused developments in rheumatology
The litigation covers NAION claims tied to multiple GLP-1 medications, including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound
The high prices in the United States spurred a Senate hearing this fall that drew attention to the nations complex drug pricing system